These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 15060829)

  • 1. The prognostic value of the otoacoustic emission test in low frequency sudden hearing loss.
    Canale A; Lacilla M; Giordano C; De Sanctis A; Albera R
    Eur Arch Otorhinolaryngol; 2005 Mar; 262(3):208-12. PubMed ID: 15060829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On a possible prognostic value of otoacoustic emissions: a study on patients with sudden hearing loss.
    Hoth S
    Eur Arch Otorhinolaryngol; 2005 Mar; 262(3):217-24. PubMed ID: 15133692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Otoacoustic emissions in the prediction of sudden sensorineural hearing loss outcome.
    Shupak A; Zeidan R; Shemesh R
    Otol Neurotol; 2014 Dec; 35(10):1691-7. PubMed ID: 25321887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transiently evoked otoacoustic emissions as a prognostic indicator in idiopathic sudden hearing loss.
    Lalaki P; Markou K; Tsalighopoulos MG; Daniilidis I
    Scand Audiol Suppl; 2001; (52):141-5. PubMed ID: 11318448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
    Hoth S
    Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Otoacoustic emissions, ear fullness and tinnitus in the recovery course of sudden deafness.
    Ishida IM; Sugiura M; Teranishi M; Katayama N; Nakashima T
    Auris Nasus Larynx; 2008 Mar; 35(1):41-6. PubMed ID: 17904320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distortion product otoacoustic emissions as a prognostic factor for idiopathic sudden sensorineural hearing loss.
    Chao TK; Chen TH
    Audiol Neurootol; 2006; 11(5):331-8. PubMed ID: 16983184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Distortion product of otoacoustic emissions in normal hearing and sensorineural hearing loss].
    Schlögel H; Stephan K; Böheim K; Welzl-Müller K
    HNO; 1995 Jan; 43(1):19-24. PubMed ID: 7890546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of hearing outcomes by distortion product otoacoustic emissions in patients with idiopathic sudden sensorineural hearing loss.
    Mori T; Suzuki H; Hiraki N; Hashida K; Ohbuchi T; Katoh A; Udaka T
    Auris Nasus Larynx; 2011 Oct; 38(5):564-9. PubMed ID: 21324619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distortion product otoacoustic emissions and tympanometric measurements in an adult population-based study.
    Uchida Y; Ando F; Nakata S; Ueda H; Nakashima T; Niino N; Shimokata H
    Auris Nasus Larynx; 2006 Dec; 33(4):397-401. PubMed ID: 16753276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Otoacoustic emissions in sudden deafness].
    Mozota Núñez JR; Mozota Núñez ML; Mozota Núñez MJ; Vila Mendiburu I; Mozota Ortiz JR
    An Otorrinolaringol Ibero Am; 2003; 30(3):289-300. PubMed ID: 12918293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early diagnosis of endolymphatic hydrops with distortion. Product otoacoustic emissions.
    Magliulo G; Cianfrone G; Di Cello P; Tersigni A
    An Otorrinolaringol Ibero Am; 2004; 31(2):173-89. PubMed ID: 15185614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of middle-ear effusion on otoacoustic emissions.
    Yeo SW; Park SN; Park YS; Suh BD
    J Laryngol Otol; 2002 Oct; 116(10):794-9. PubMed ID: 12437833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Distortion product otoacoustic emissions in sensorineural hearing loss].
    Skotnicka B; Hassmann-Poznańska E
    Otolaryngol Pol; 1999; 53(6):693-8. PubMed ID: 10763321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Otoacoustic emissions measurements in children during the chemotherapy because of the acute lymphoblastic leukemia].
    Lisowska G; Namysłowski G; Hajduk A; Polok A; Tomaszewska R; Misiołek M
    Otolaryngol Pol; 2006; 60(3):415-20. PubMed ID: 16989457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Otoacoustic emissions in a hearing conservation program: general applicability in longitudinal monitoring and the relation to changes in pure-tone thresholds.
    Helleman HW; Jansen EJ; Dreschler WA
    Int J Audiol; 2010 Jun; 49(6):410-9. PubMed ID: 20192875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of distortion product otoacoustic emissions and pure tone audiometry in occupational screening for auditory deficit due to noise exposure.
    Wooles N; Mulheran M; Bray P; Brewster M; Banerjee AR
    J Laryngol Otol; 2015 Dec; 129(12):1174-81. PubMed ID: 26549131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subclinical dysfunction of cochlea and cochlear efferents in migraine: an otoacoustic emission study.
    Bolay H; Bayazit YA; Gündüz B; Ugur AK; Akçali D; Altunyay S; Ilica S; Babacan A
    Cephalalgia; 2008 Apr; 28(4):309-17. PubMed ID: 18279433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hearing threshold estimation using concurrent measurement of distortion product otoacoustic emissions and auditory steady-state responses.
    Rosner T; Kandzia F; Oswald JA; Janssen T
    J Acoust Soc Am; 2011 Feb; 129(2):840-51. PubMed ID: 21361442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in input/output function of distortion product otoacoustic emissions during the glycerol test in Ménière's disease.
    Sakashita T; Shibata T; Yamane H; Hikawa C
    Acta Otolaryngol Suppl; 2004 Oct; (554):26-9. PubMed ID: 15513506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.